Nanoparticles used to create topical Viagra rival
Erectile dysfunction could be treated by a nanoparticle formulation applied directly to the penis, according to research, reducing the side effects that can occur when taking drugs like Viagra.
Archives for April 28, 2009
Microsoft launches Amalga for R&D and trial data management
US software giant Microsoft has unveiled its new Amalga Life Sciences data aggregation and modelling platform in a bid to capitalise on the demand for IT infrastructure solutions currently sweeping the drug R&D and trials sectors.
Icon’s growth slows and new business falls
Icon’s net new business fell by 28 per cent in Q1 but the overall picture was better, with operating profits rising by 25 per cent and a US acquisition expanding its Phase I capacity.
Sanofi pulls plug on four Ph III drugs
Sanofi-Aventis has halted development of four Phase III drugs in a “rigorous” pre-patent loss pipeline review that has also seen it drop four Phase II candidates and six Phase I projects.
GEA probe helps companies follow PAT initiatives
GEA Pharma Systems’ process equipment is now available with its Lighthouse Probe technology, which uses fibre optics and mirrors to give a clear view of the product when it is in the machine.
Ability to hit deadlines, not cost, top CRO quality, survey finds
19 out of 21 pharmaceutical companies surveyed by Cutting Edge Information ranked a contract research organisation’s ability to hit trial deadlines as either “extremely important” or very “important,” making it the top quality identified by respondents.